 |
|
 |
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PEDIATRICS Vol. 107 No. 6 June 2001, p. e93
,
From the Departments of * Pediatrics and Background. Macroamylasemia (MA) is a
benign condition caused by circulating macroamylase complexes of
pancreatic or salivary amylase bound to plasma proteins, which cannot
be cleared by the renal glomeruli. In most cases, the macromolecular
amylase represents a complex of normal amylase and either
immunoglobulin A or G and may be a specific antigen-antibody complex.
Celiac disease (CD) is a permanent intolerance to ingested gluten that
results in immunologically mediated inflammatory damage of the small
intestinal mucosa. Several recent population-based serologic surveys
have shown CD to be a common disorder, possibly affecting 1 in 200 to
250 individuals in most countries studied, including the United States,
where overt CD is rare, indicating a high proportion of subclinical
disease. The diagnosis of CD currently rests on the histological
demonstration of the characteristic lesion in the small intestine and
the subsequent clinical response to the introduction of a gluten-free
diet. MA associated with CD has been described in adult patients, and
in a few cases, MA decreased or resolved after a strict gluten-free
diet. A few single cases of MA have been described in childhood, but no
association with CD has been reported so far. We report a girl with CD,
autoimmune thyroiditis, and MA, in whom CD-related antibodies to
amylase and to exocrine pancreas tissue resolved with a gluten-free
diet.
Case Report. An 11-year-old girl was referred for chronic
abdominal pain and growth retardation associated with persistent
hyperamylasemia and suspected chronic pancreatitis. We confirmed
elevated serum amylase, normal serum lipase, and very low 24-hour urine
amylase and amylase clearance/creatinine clearance ratio, consistent
with MA. Serologic tests for CD were positive, and the diagnosis was confirmed by small bowel biopsy showing subtotal villous atrophy. Thyroid function tests showed a pronounced hypothyroidism, associated with high titers of thyroid microsomal and thyroglobulin
antibodies. Screening for other autoantibodies Study Design and Methods. The patient's serum samples
were obtained at the time of CD diagnosis and at 3 and 12 months after
instituting a gluten-free diet. Serum samples from 10 consecutive
untreated celiac children were disease controls, and 39 participants
with no gastrointestinal symptoms and no family history of CD served as
healthy controls. The origin of MA as determined by complexes of
amylase with circulating immunoglobulins was tested by the measurement
of amylase on supernatants after precipitation of immune complexes with
either protein A Sepharose or polyethylene glycol. The precipitation of
>60% of amylase activity was consistent with the presence of MA.
Immunoglobulin G (IgG) and immunoglobulin A (IgA) circulating
autoantibodies to amylase were measured using recently developed
enzyme-linked immunosorbent assay (ELISA), using porcine amylase as
antigen. Results were expressed as arbitrary units (AUs). Statistical
analysis was performed by Student's t test for unpaired
data. IgA and IgG antibodies to exocrine pancreas tissue were detected
by indirect immunofluorescence on human pancreas cryosections.
Results. Serum immunoprecipitation with either protein A
Sepharose or polyethylene glycol reduced amylase activity from 1698 to
89 U/L (94.8%) and to 75 U/L (95.6%), with only marginal reduction in
control serum samples. The ELISA for autoantibodies to amylase detected
high values, both IgA (3531 AU) and IgG (1855 AU), in the serum sample
from the patient at CD diagnosis. IgA autoantibodies (mean ± standard deviation) were 3.4 ± 2.5 AU in healthy controls, and
2.1 ± 1.2 AU in celiac controls; IgG autoantibodies were 10 ± 4.8 AU in healthy controls and 8.5 ± 3.2 AU, respectively.
Autoantibodies to exocrine pancreas tissue were documented in patient
sera at the time of CD diagnosis, both IgA and IgG, but not in control groups. Preincubation of patient's serum with excess of Conclusions. Few cases of MA have been described in
children, and in all amylase determination was part of the clinical
investigation for abdominal pain or trauma. We describe the first
pediatric case report of MA associated with CD and autoimmune
thyroiditis. The association of autoimmunity to exocrine pancreas
tissue with CD is intriguing. CD is frequently found in association
with pancreatic islet cell autoimmunity and with clinical type 1 diabetes. In our case, endocrine pancreas seemed to be spared by the
autoimmune process, because we could not demonstrate islet cell and
islet-specific autoantibodies. A relationship of pancreatic
autoimmunity and CD is suggested by the parallel decline and
disappearance of both CD and pancreas autoantibodies after gluten
withdrawal. These finding are consistent with the increasing
recognition of autoantibodies as a manifestation of CD and regression
of these antibodies with treatment of a gluten-free diet. The
mechanisms underlying the formation of MA in CD and the site of
production of amylase-binding antibodies have been poorly defined and
can only be hypothesized. It is possible that at the intestinal level,
crossreactivity either with gluten-related or other antigens occurs,
resulting in autoantibody formation to pancreas serum amylase.
Nevertheless, our findings suggest a correlation between CD and MA,
because it resolved with institution of a gluten-free diet. Because CD
may be silent and undiagnosed, we suggest screening for the disease in
patients with MA.
Medicine, Scientific
Institute H San Raffaele, University of Milan, Milan, Italy.
ABSTRACT
Top
Abstract
Methods
Results
Discussion
References
including
antinuclear, islet cell, glutamic acid decarboxylase, protein tyrosine
phosphatase islet antigen 512, adrenal gland, and cytoplasmic
neutrophil granulocyte antibodieswas negative. A diagnosis of CD, MA,
and hypothyroidism attributable to autoimmune thyroiditis was made. A
gluten-free diet and oral replacement with L-thyroxine was
started with clinical improvement. Serum amylase and amylase
clearance/creatinine clearance ratio normalized, consistent with
resolution of MA.
-amylase specifically inhibited antibody binding to coated amylase in the ELISA,
and partially inhibited immunoreactivity to exocrine pancreas. Autoantibodies to -amylase and to exocrine pancreas declined in CD
patients after institution of a gluten-free diet.
Macroamylasemia (MA) is a benign condition caused by
circulating macroamylase complexes of pancreatic or salivary amylase bound to plasma proteins, which cannot be cleared by the renal glomeruli.1 The finding of elevated serum amylase activity in the presence of low urinary amylase should alert the clinician to
the presence of MA.1,2 In most cases, the macromolecular
amylase represents a complex of normal amylase and either
immunoglobulin A (IgA)1-6 or immunoglobulin G
(IgG)1,6 and may be a specific antigen-antibody
complex.1,2 Although MA has been described among patients
with malabsorption, chronic alcoholism, cancer, autoimmune disorders,
liver disease, and diabetes, these associations are thought to be
incidental.
Celiac disease (CD) is a permanent intolerance to ingested gluten that
results in immunologically mediated inflammatory damage of the small
intestinal mucosa.7 The classic clinical presentation of
malabsorption has become less common. Atypical features, such as
nonspecific gastrointestinal complaints, short stature, iron deficiency
anemia, and dental abnormalities, may predominate. However, the
majority of patients have what is termed silent CD, which may remain
undiagnosed because the condition has no symptoms. Several recent
population-based serologic surveys have shown CD to be a common
disorder, possibly affecting 1 in 200 to 250 individuals in most
countries studied, including the United States, where overt CD is rare,
indicating a high proportion of subclinical disease.7 The
diagnosis of CD currently rests on the histologic demonstration of the
characteristic lesion in the small intestine and the subsequent
clinical response to the introduction of a gluten-free
diet.8 Serologic studies are now used to further confirm
the diagnosis and to screen populations at risk for the disease. These
include the enzyme-linked immunosorbent assay (ELISA) for IgA
antibodies to gliadin and the immunofluorescence test for IgA
antibodies to endomysium, the presence of which is virtually
pathognomonic for CD. Measurement of antitissue transglutaminase antibodies might be an alternative and more objective method for detecting antiendomysium antibodies, proving to be highly sensitive and
specific.9
MA associated with proven2,4,510-13 or
likely3,14,15 CD has been described in adult patients. In
a few cases,2,4,10,13,14 MA decreased or resolved after a
strict gluten-free diet, whereas in others it did not.5,11
A few single cases of MA have been described in
childhood,16-20 but no association with CD has been
reported so far.
We report a girl with CD, autoimmune thyroiditis, and MA, in whom
CD-related antibodies to amylase and to exocrine pancreas tissue
resolved with a gluten-free diet.
An 11-year-old girl was referred for chronic abdominal pain and
growth retardation associated with persistent hyperamylasemia and
suspected chronic pancreatitis. Physical examination revealed height of
1.30 m (<third percentile), weight of 25 kg (<third percentile),
prepubertal state, dry skin, and mild abdominal distension. We
confirmed elevated serum amylase, normal serum lipase, and very low
24-hour urine amylase and amylase clearance/creatinine clearance
(amCl/crCl) ratio (Table 1), consistent
with MA. Abdominal ultrasonography and magnetic resonance
cholangiopancreatography were normal. Serologic tests for CD (Table 1)
were positive, and the diagnosis was confirmed by small bowel biopsy
showing subtotal villous atrophy. Thyroid function tests showed a
pronounced hypothyroidism with elevated thyroid-stimulating hormone
(969 mU/L; normal values = 0.27-4.2), low free triiodothyronine (0.8 ng/L; normal values = 1.8-4.6), and low free thyroxine (1.3 pmol/L; normal values = 11.5-24.5), associated with high titers of thyroid microsomal and thyroglobulin antibodies. Screening for other
autoantibodies TABLE 1
CASE REPORT
including antinuclear, islet cell, glutamic acid
decarboxylase, protein tyrosine phosphatase islet antigen 512, adrenal
gland, and cytoplasmic neutrophil granulocyte antibodieswas negative.
A diagnosis of CD, MA, and hypothyroidism attributable to autoimmune
thyroiditis was made. A gluten-free diet and oral replacement with
L-thyroxine was started with clinical improvement (weight
gain = 8 kg/year; height velocity = 12 cm/year). Serum
amylase and amCl/crCl ratio normalized, consistent with resolution of
MA.
Patient's Biochemical and Serologic Data at CD Diagnosis 3 and 12 Months After Gluten-Free
Diet
| |
METHODS |
|---|
|
Top
Abstract
Methods
Results
Discussion
References
|
|---|
Patient and Control Sera
The patient's serum samples were obtained at the time of CD diagnosis and at 3 and 12 months after instituting a gluten-free diet. Serum samples from 10 consecutive untreated celiac children (mean age: 8.8 years; range: 6.4-11.8) fulfilling the European Society of Pediatric Gastroenterology, Hepatology, and Nutrition criteria8 were disease controls; thyroid function was normal in all. Thirty-nine participants (mean age: 10 years; range: 6.1-12.3) with no gastrointestinal symptoms and no family history of CD served as healthy controls. All studies of celiac and healthy control participants were performed in accordance with the ethic rules of the institute.
MA as a Complex of Amylase With Immunoglobulins
The origin of MA as determined by complexes of amylase with circulating immunoglobulins was tested by the measurement of amylase on supernatants after precipitation of immune complexes with either protein A Sepharose or polyethylene glycol. The precipitation of >60% of amylase activity was consistent with the presence of MA.21
Amylase Antibodies by ELISA
IgG and IgA circulating autoantibodies to amylase were measured using a recently developed ELISA,6 using porcine amylase as antigen. Results were expressed as arbitrary units (AUs). Statistical analysis was performed by Student's t test for unpaired data.
Exocrine Pancreas Antibodies by Immunofluorescence
IgA and IgG antibodies to exocrine pancreas tissue were detected by indirect immunofluorescence on human pancreas cryosections.22
Specificity of Antibody Binding to Amylase
Specificity of antibodies for amylase was tested by inhibition of antibody binding with antigen excess in the ELISA and immunofluorescence reactivity assay on pancreas cryosections. All 3 patient's serum samples and serum samples of 4 control participants were retested in the 2 assays after competition with porcine amylase. Sera (25 µL) were incubated with amylase preparation (5 µg in 25 µL) for 1 hour at 4°C and then tested in the 2 assays.
| |
RESULTS |
|---|
|
Top
Abstract
Methods
Results
Discussion
References
|
|---|
Serum immunoprecipitation with either protein A Sepharose or polyethylene glycol reduced amylase activity from 1698 to 89 U/L (94.8%) and to 75 U/L (95.6%), with only marginal reduction in control serum samples.
Autoantibodies to -amylase declined in CD patients after institution
of a gluten-free diet (Fig 1).
Preincubation of patient's serum with excess of -amylase
specifically inhibited antibody binding to coated amylase in the ELISA.
|
IgA and IgG class autoantibody results to exocrine pancreas tissue,
detected in patient's sera, are reported in Table 1; they were
undetectable in either control group. Preincubation with excess of
-amylase only partially inhibited immunoreactivity to exocrine
pancreas.
| |
DISCUSSION |
|---|
|
Top
Abstract
Methods
Results
Discussion
References
|
|---|
Few cases of MA have been described in children,16-20 and in all cases, amylase determination was part of the clinical investigation for abdominal pain or trauma. Amylase-IgA16 or amylase-IgG18,19 immunocomplexes were documented by immunoelectrophoresis16,18 or fast protein liquid chromatography.19 No pancreatic damage was demonstrated, and MA persisted despite the disappearance of abdominal pain.16-19 We describe the first pediatric case report of MA associated with CD and autoimmune thyroiditis. We also quantitatively measured IgA and IgG autoantibodies to amylase by ELISA and to human exocrine pancreas by immunofluorescence.
The association of autoimmunity to exocrine pancreas tissue with CD is intriguing. CD is frequently found in association with pancreatic islet cell autoimmunity23 and with clinical type 1 diabetes.24 In our case, endocrine pancreas seemed to be spared by the autoimmune process, because we could not demonstrate islet cell and islet-specific autoantibodies. A relationship of pancreatic autoimmunity and CD is suggested by the parallel decline and disappearance of both CD and pancreas autoantibodies after gluten withdrawal. These findings are consistent with the increasing recognition of autoantibodies as a manifestation of CD23,25,26 and with regression of these antibodies with treatment of a gluten-free diet.23 Autoimmune diseases are also quite common in CD, and a pathogenetic role of gluten has been suggested as a major risk factor.24 Although according to recent literature23,25,26 up to 24% to 52.6% of patients may demonstrate an organ-specific autoantibody, we showed that amylase antibodies are not a common feature of CD, because they were undetectable in 10 untreated celiac controls.
The mechanisms underlying the formation of MA in CD and the site of production of amylase-binding antibodies have been poorly defined and can only be hypothesized. It is possible that at the intestinal level crossreactivity either with gluten-related or other antigens occurs, resulting in autoantibody formation to pancreas serum amylase. Direct sensitization attributable to pancreatic tissue destruction seems less likely because no other signs of tissue damage were found in this case. Nevertheless, our findings suggest a correlation between CD and MA, because it resolved with institution of a gluten-free diet. Interestingly, in the few cases of MA described in childhood, it was reported to persist,16-20 because no pathogenetic mechanisms and effective treatment were recognized. Therefore, we hypothesize that some patients with MA are associated with silent CD. Because CD may be asymptomatic,7 we suggest screening for CD in children with MA.
| |
ACKNOWLEDGMENT |
|---|
We thank Dr Franco Cazzulani for referring this patient for study and advice.
| |
FOOTNOTES |
|---|
Reprint request to (G.B.) Pediatric Department, University of Milan, Scientific Institute H San Raffaele, Via Olgettina, 60, 20132 Milan, Italy. E-mail: barera.graziano{at}hsr.it
Received for publication Jul 3, 2000; accepted Jan 17, 2001.
| |
ABBREVIATIONS |
|---|
MA, macroamylasemia; IgA, immunoglobulin A; IgG, immunoglobulin G; CD, celiac disease; ELISA, enzyme-linked immunosorbent assay; AmCl/crCl, amylase clearance/creatinine clearance; AU, arbitrary unit.
| |
REFERENCES |
|---|
|
Top
Abstract
Methods
Results
Discussion
References
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
||
|
||
Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 2001 American Academy of Pediatrics. All rights reserved. |
||
|
||
